Alexandra Migdal, MD

Assistant Professor of Medicine

Department of Medicine


1. Farr O, Upadhyay J, Gavrieli A, Camp M. Spyrou N, Kaye H, Mathew H, Vamvini M, Koniaris A, Kilim H, Srnka A, Migdal A, Mantzoros C. Lorcaserin administration decreases activation of brain centers in response to food cues and these emotion-and salience-related changes correlate with weight loss effects: a four week long randomized, placebo-controlled, double-blinded clinical trial. Diabetes. 2016 Jun, Epub ahead of print.

2. Migdal A, Sternberg S, Oshin A, Aronson M, Hennessey J. Building a Quality Management System for a Thyroid Nodule Clinic. Thyroid. 2016 Jun; 26(6):825-830.

3. Migdal A, Abrahamson M. “Treating Type 2 Diabetes Mellitus” in Principles of Diabetes Mellitus, Third Edition. Leonid Poretsky, Eds. Springer International Publishing; 3rd edition (2016).

4. Newton CA, Adeel S, Sadeghi-Yarandi S, Powell W, Migdal A, Smiley D, Olson D, Chambria R, Pinzon I, Toyoshima M, Nagamia Z, Peng L, Johnson T, Umpierrez GE. Prevalence, quality of care, and complications in long term care residents with diabetes: a multicenter observational study. J Am Med Dir Assoc. 2013 Nov; 14(11):842-6.

5. Migdal, A, Hennessey, J. “Psychiatric Disorder and Thyroid Disease” in Endocrine Secrets, 6 Michael McDermott, Eds. W.B. Saunders Company; 6th edition (May 1, 2013).

6. Migdal, A, Yarandi, S, Smiley, D, Umpierrez, G. Update on Diabetes in the Elderly and in Nursing Home Residents. Journal of the American Medical Directors Association, 2011; 12: 627-632.

7. Asnis, G, Migdal, A, Ryan, E, Dieterich, D, Morgello, S. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 2006; 64: 768

8. De La Garza, R, Asnis, G, Pedrosa, E,Stearns, C, Migdal, A, Reinus, J, Paladugu, R, Vemulapalli, S. Recombinant Human Interferon- Does Not Alter Reward Behavior, or Neuroimmune and Neuroendocrine Activation in Rats. Progress in Neuropsychopharmacology & Biological Psychiatry, 2005; 29: 781-792.